Plasma Insulin is Removed by Hemodialysis: Evaluation of the Relation Between Plasma Insulin and Glucose by Using a Dialysate With or Without Glucose

Therapeutic Apheresis and Dialysis - Tập 11 Số 4 - Trang 280-287 - 2007
Masanori Abe1, Kazo Kaizu2, Koichí Matsumoto1
1Division of Nephrology and Endocrinology, Department of Medicine, Nihon University School of Medicine, Tokyo, and
2Department of Nephrology and Blood Purification, Yokohama Social Insurance Central Hospital, Yokohama, Japan

Tóm tắt

Abstract:  The aim of the present study was to evaluate the alteration in plasma immunoreactive insulin (IRI) and glucose concentrations due to hemodialysis (HD) treatment by using a dialysate with or without glucose in HD patients. We divided the patients into three groups: non‐diabetic patients (n‐DM group), well‐controlled diabetic patients (HbA1c <7.0% [w‐DM group]), and poorly‐controlled diabetic patients (HbA1c≥7.0% [p‐DM group]). Using a dialysate with a glucose concentration of 100 mg/dL (glu(+)‐dialysate) and a glucose‐free dialysate (glu(−)‐dialysate), we studied the daily profiles of plasma glucose in the three groups. We measured the levels of plasma glucose and IRI at three time points (predialysis and 2 h and 4 h after the initiation of dialysis) at pre(A) and postdialyzer (V) sites in HD patients. There was a significant increase in the daily profiles of the plasma glucose level from the time before dinner until bedtime in both the w‐DM and p‐DM groups, when comparing the values on an HD day with those on a non‐HD day. In the p‐DM group, the use of the glu(−)‐dialysate resulted in a significant hyperglycemia in the evening hours when compared with the use of the glu(+)‐dialysate. In the DM group, the use of the glu(+)‐dialysate resulted in a significant decrease in the plasma glucose and IRI levels during HD. However, in the n‐DM group, there was no difference in the plasma glucose levels during HD. On the other hand, the use of a glucose‐free dialysate led to a significant decrease in the plasma glucose and IRI levels during HD in all groups. The plasma IRI levels decreased significantly between the A and V sites at each point in all groups irrespective of the glucose concentration of the dialysate. The present study confirmed that the concentration of not only glucose but also IRI had decreased during the passage of the plasma through the dialyzer. In HD patients with diabetes, the glucose content of the hemodialysis solution plays an important role in preventing acute hypoglycemia and hyperglycemia on HD days.

Từ khóa


Tài liệu tham khảo

10.2337/diabetes.48.5.937

10.1007/BF00401063

10.2337/diab.43.8.960

10.2337/diacare.27.2007.S15

10.2337/diacare.24.5.909

Haviv YS, 1999, Hypoglycaemia in 56 hemodialysis patients: incidence and outcome, Dial Transplant, 28, 574

Oshida Y, 1987, Studies on glucose intolerance in chronic renal failure: estimation of insulin sensitivity before and after initiation of hemodialysis, Clin Nephrol, 28, 35

10.1159/000188997

Simic OS, 2001, The influence of different glucose concentrations in haemodialysis solutions on metabolism and blood pressure stability in diabetic patients, Int J Artif Organs, 24, 863, 10.1177/039139880102401210

Avram MM, 1976, Metabolic changes in diabetic uremic patients on hemodialysis, Trans Am Soc Artif Intern Organs, 22, 412

Wathem RL, 1978, The metabolic effects of hemodialysis with and without glucose in the dialysate, Am J Clin Nutr, 31, 1870, 10.1093/ajcn/31.10.1870

10.1172/JCI108409

Bagdade JD, 1970, Uremic lipemia. An unrecognized abnormality in triglyceride production and removal, Arch Intern Med, 87, 506

10.1161/01.CIR.97.17.1695

10.1172/JCI11235

10.1038/sj.ijo.0802172

Thông tin
Thông tin xuất bản

Therapeutic Apheresis and Dialysis

Tập 11 Số 4

280-287

Thông tin tác giả